MedPath

Clinical evaluation of the SSSLTVSPWY peptide labeled with 68Ga

Not Applicable
Recruiting
Conditions
Breast cancer.
Malignant neoplasm of breast of unspecified site, female
C50.91
Registration Number
IRCT20230312057691N1
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
25
Inclusion Criteria

Patients with HER2-overexpressed breast tumors (primary or metastatic mass) after screening with IHC test (with 3+ result) or FISH test

Exclusion Criteria

Pregnancy
Breastfeeding
Uncontrolled kidney and liver disorders
A history of allergy to radiopharmaceuticals

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath